Home > Newsletters > International Pharmaceutical Regulatory Monitor > Expert Calls on U.S. FDA to Guide Americans to More Legitimate Foreign Drug Websites
International Pharmaceutical Regulatory Monitor
November 2012 | Vol. 40 No. 11
Expert Calls on U.S. FDA to Guide Americans to More Legitimate Foreign Drug Websites
Although the U.S. Food and Drug Administration (FDA) cannot legally endorse foreign websites selling pharmaceuticals to U.S. customers, a leading expert in counterfeit and substandard drugs is urging the agency to at least guide Americans to more legitimate sources or website-credentialing agencies.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.